CSL (ASX:CSL) Share Price and News - StockTrack

Market Cap (19-Sep) $51,487,825,920 (6th)	Close (30-Jun) $277.38 0 (0%)	Volume (30-Jun) 970,129	Shortsold (26-May) 3,074,475 (0.64%) (287th)
52w High $269.15	52w Low $90.00	P/E 11.89	EPS 8.76
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 4+

	Subject
	CSL Ann: Application for quotation of securities - CSL
	1 (current) 2 3
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: CSL Annual Report 2022
	CSL Ann: CSL Appendix 4G
	CSL Ann: CSL Notice of Meeting and Shareholder Pack 2022
	CSL Ann: Change of Director's Interest Notice (x8)
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Update - Dividend/Distribution - CSL
	CSL Ann: CSL Results Presentation
	CSL Ann: Dividend/Distribution - CSL
	CSL Ann: CSL Results Announcement
	CSL Ann: CSL Statutory Accounts for the Full Year Ended 30 June 202
	CSL Ann: Notice of Investor/Analyst Briefing 2022 Full Year Result
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Completion of Vifor Pharma Acquisition
	CSL Ann: Finalisation of Vifor Pharma Acquisition
	CSL Ann: Becoming a substantial holder
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Vifor update ASX Announcement for lodgement
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Macquarie Presentation 2022
	CSL Ann: CSL successfully issues bonds in US debt markets
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Update - Dividend/Distribution - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Update on Acquisition of Vifor Pharma
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Dividend/Distribution - CSL
	CSL Ann: Half Year Results Investor Presentation
	CSL Ann: Half Year Results Announcement
	CSL Ann: Statutory Accounts for Half Year Ended 31 December 2021
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: CSL completes A$750 million Share Purchase Plan
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Proposal to Appoint Deloitte as External Auditor
	CSL Ann: Share Purchase Plan
	CSL Ann: Notice under section 708A(5)(e) of the Corporations Act
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: Successful Completion of A$6.3B Institutional Placement
	CSL Ann: Proposed issue of securities - CSL

Similar Companies

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$198.34	2,097,346	-9.48 (4.56%)
12-Sep	$207.82	1,061,162	+2.01 (0.98%)
11-Sep	$205.81	1,481,808	-3.44 (1.64%)
05-Sep	$209.25	1,145,142	-1.60 (0.76%)
04-Sep	$210.85	1,184,425	+4.23 (2.05%)
03-Sep	$206.62	1,235,226	-6.27 (2.95%)
29-Aug	$212.89	1,120,057	+0.19 (0.09%)
28-Aug	$212.70	788,032	-3.90 (1.80%)
22-Aug	$216.60	2,451,697	-9.40 (4.16%)
21-Aug	$226.00	2,278,663	-44.37 (16.41%)
15-Aug	$270.37	600,591	+0.27 (0.10%)
14-Aug	$270.10	499,742	+4.57 (1.72%)
07-Aug	$265.53	642,872	-5.37 (1.98%)
31-Jul	$270.90	1,068,920	-0.21 (0.08%)
30-Jul	$271.11	653,979	-0.89 (0.33%)
5 up, 10 down, and 0 flat days

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

$277.38 -0.92 (-0.33%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

CSL Health Care Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

$277.38 -0.92 (-0.33%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma